Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

Rhea-AI Summary

CorMedix Therapeutics (Nasdaq: CRMD) will participate in two upcoming investor conferences in New York, featuring fireside chats and investor meetings.

The company presents at the RBC Capital Markets Global Healthcare Conference on May 20, 2026, and the Jefferies Global Healthcare Conference on June 3, 2026, with live webcasts available.

News Market Reaction – CRMD

-4.79%

-4.79% Session close to close

In the May 15 session, CRMD declined 4.79%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:

RBC Capital Markets Global Healthcare Conference
Date:	Wednesday, May 20, 2026
Time:	11:00am EDT
Webcast:	Click here

Jefferies Global Healthcare Conference
Date:	Wednesday, June 3, 2026
Time:	4:20pm EDT
Webcast:	Click here

About CorMedix

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers.  For more information visit: www.cormedix.com.

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576

FAQ

When will CorMedix Therapeutics (CRMD) present at the RBC Capital Markets Global Healthcare Conference 2026?

CorMedix Therapeutics will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026 at 11:00 a.m. EDT. According to CorMedix, investors can access the presentation via a live webcast provided for the event.

What are the details of CorMedix Therapeutics (CRMD) fireside chat at the Jefferies Global Healthcare Conference 2026?

CorMedix Therapeutics will host a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:20 p.m. EDT. According to CorMedix, the session will be accessible to investors through a webcast.

How can investors access the CorMedix Therapeutics (CRMD) webcasts for the May and June 2026 conferences?

Investors can access CorMedix Therapeutics’ conference appearances via live webcasts linked for each event. According to CorMedix, webcast access will be available for both the May 20 RBC conference and the June 3 Jefferies conference.

What is the purpose of CorMedix Therapeutics (CRMD) participating in the 2026 RBC and Jefferies healthcare conferences?

CorMedix Therapeutics is participating to engage investors through fireside chats and meetings. According to CorMedix, management will discuss the business with institutional investors during these New York healthcare conferences in May and June 2026.

What type of company is CorMedix Therapeutics (CRMD) and where does it operate?

CorMedix Therapeutics is a biopharmaceutical company focused on prevention and treatment of life-threatening conditions in the United States. According to CorMedix, it sells and markets products in institutional care settings, including hospitals, clinics, and infusion centers.